Showing results (151-160 of 995) with videos related to

Sort By:
Pageof 100
Journal of Translational Medicine|December 16, 2018
Implementing a comprehensive translational oncology platform: from molecular testing to actionabilityZahi I Mitri, Swapnil Parmar, Brett Johnson, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2019
Cyclic Multiplexed-Immunofluorescence (cmIF), a Highly Multiplexed Method for Single-Cell AnalysisJennifer Eng, Guillaume Thibault, Shiuh-Wen Luoh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancerYinghui Guan, Wen-Lin Kuo, Jackie L Stilwell, et al.
BMC Medical Genomics|February 21, 2009
High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarraysYuker Wang, Victoria E H Carlton, George Karlin-Neumann, et al.
Nature Reviews. Drug Discovery|December 13, 2005
Exploiting the PI3K/AKT pathway for cancer drug discoveryBryan T Hennessy, Debra L Smith, Prahlad T Ram, et al.
Cell|April 17, 2026
Targeting genomic instability in cancerTimothy A Yap, H Charles Manning, Puja Sapra, et al.
Molecular Oncology|March 23, 2013
EVI1 splice variants modulate functional responses in ovarian cancer cellsPunashi Dutta, Tuyen Bui, Kyle A Bauckman, et al.
Molecular Cancer Therapeutics|December 17, 2002
Inhibition of the phosphatidylinositol 3'-kinase-AKT pathway induces apoptosis in pancreatic carcinoma cells in vitro and in vivoVictor M Bondar, Bridget Sweeney-Gotsch, Michael Andreeff, et al.
Journal of Medicinal Chemistry|December 12, 2003
Enantioselective responses to a phosphorothioate analogue of lysophosphatidic acid with LPA3 receptor-selective agonist activityLian Qian, Yong Xu, Yutaka Hasegawa, et al.
Pageof 100